Zhigang Wang - Department of Pharmaceutical and Pharmacological Sciences, KU Leuven

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 17 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Therapeutic Drug Monitoring 2.0: Time to Assemble the Puzzle

Zhigang Wang,Erwin Dreesen

INFLAMMATORY BOWEL DISEASESno. 2 (2024): 316-317

引用0浏览0引用

The PPP2R1A Cancer Hotspot Mutant P.r183w Increases Clofarabine Resistance in Uterine Serous Carcinoma Cells by a Gain-of-function Mechanism

Michiel Remmerie,Rüveyda Dok,Zhigang Wang,Judit Domènech Omella, Sophie Alen, Célie Cokelaere,Lisa Lenaerts,Erwin Dreesen,Sandra Nuyts,Rita Derua,Veerle Janssens

CELLULAR ONCOLOGYno. 5 (2024): 1811-1829

引用0浏览0WOS引用

Su1822 USTEKINUMAB DRUG CLEARANCE IS BETTER ASSOCIATED WITH CROHN'S DISEASE REMISSION THAN SERUM TROUGH CONCENTRATIONS IN PROSPECTIVE COHORT STUDY

Andres Yarur,Thierry Dervieux,Ryan C. Ungaro,Alexandra Bruss,Brandon Berens,Lizbeth Nunez,Severine Vermeire,Zhigang Wang,Erwin Dreesen,Marla C. Dubinsky

GASTROENTEROLOGYno. 5 (2024): S829-S830

引用0浏览0引用

Therapeutic Drug Monitoring Can Guide the Intravenous-to-subcutaneous Switch of Infliximab and Vedolizumab: a Pharmacokinetic Simulation Study

Z. Wang,B. Verstockt,J. Sabino,M. Ferrante,S. Vermeire,E. Dreesen

Journal of Crohn's and colitis（2023）

引用5浏览0WOS引用

Tu1759 INFLIXIMAB AND PREVENTION OF COLECTOMY IN ACUTE SEVERE ULCERATIVE COLITIS: AN INDIVIDUAL PATIENT DATA META-ANALYSIS

Zhigang Wang,Waqqas Afif,Jurij Hanžel,Taku Kobayashi,Konstantinos Papamichail,Xavier Roblin,Laurent Peyrin‐Biroulet,Séverine Vermeire,Erwin Dreesen

Gastroenterologyno. 6 (2023): S-1113

引用0浏览0引用

DOP89 Infliximab and Ustekinumab Clearance During Induction Predicts Post-Induction Endoscopic Outcomes in Patients with Crohn’s Disease

Z. Wang,W. Kantasiripitak,B. Verstockt, S. Joao,M. Ferrante,P. Declerck,G. D'Haens,D. Laharie,S. Vermeire,E. Dreesen

Journal of Crohn s and Colitis（2022）

引用0浏览0引用

P333 Precise and Unbiased Infliximab Dosing in Patients with Inflammatory Bowel Diseases Using a Multi-Model Averaging Approach

W. Kantasiripitak,A. Outtier,D. Thomas, A. Kensert,Z. Wang,J. Sabino,S. G. Wicha,S. Vermeire,M. Ferrante,E. Dreesen

Journal of Crohn s and Colitisno. Supplement_1 (2022): i350-i351

引用0浏览0引用

Population pharmacokinetic-pharmacodynamic model-based exploration of alternative ustekinumab dosage regimens for patients with Crohn's disease

Zhigang Wang,Bram Verstockt,Joao Sabino,Severine Vermeire,Marc Ferrante,Paul Declerck,Erwin Dreesen

BJCP British journal of clinical pharmacology/British journal of clinical pharmacology（2022）

引用11浏览0WOS引用

Multi‐model Averaging Improves the Performance of Model‐guided Infliximab Dosing in Patients with Inflammatory Bowel Diseases

Wannee Kantasiripitak,An Outtier,Sebastian G. Wicha,Alexander Kensert,Zhigang Wang,Joao Sabino,Severine Vermeire,Debby Thomas,Marc Ferrante,Erwin Dreesen

CPT pharmacometrics & systems pharmacology（2022）

引用5浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn